Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor
about
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaDifferential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines.Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma.B cell lymphoma with different metabolic characteristics show distinct sensitivities to metabolic inhibitors.
P2860
Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Decreased expression of CXCR4 ...... as is a good prognostic factor
@ast
Decreased expression of CXCR4 ...... as is a good prognostic factor
@en
type
label
Decreased expression of CXCR4 ...... as is a good prognostic factor
@ast
Decreased expression of CXCR4 ...... as is a good prognostic factor
@en
prefLabel
Decreased expression of CXCR4 ...... as is a good prognostic factor
@ast
Decreased expression of CXCR4 ...... as is a good prognostic factor
@en
P2093
P2860
P50
P1433
P1476
Decreased expression of CXCR4 ...... as is a good prognostic factor
@en
P2093
Aleksandra Butrym
Dorota Dlubek
Ilona Kryczek
Kazimierz Kuliczkowski
Michal Jelen
P2860
P304
P356
10.1371/JOURNAL.PONE.0098194
P407
P577
2014-05-23T00:00:00Z